Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07177014

Impact of Stress First Aid for Workers in Substance Misuse Settings

Test the effectiveness of SFA adapted for the substance use outreach workforce compared to a no treatment control condition on social-support and burnout of HRWs in a cluster-randomized hybrid type I trial.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The University of Texas at Austin

Austin, Texas, 78712, United States

Location status: Recruiting

About this study

Alongside prevention, treatment, and supply reduction, outreach work is a cornerstone of the National Drug Control Strategy. However, there is a critical gap in research on the occupational health of substance use outreach workers, who are exposed to high rates of lifetime and occupational stress and trauma. High rates of unaddressed occupational stress have been shown to have an adverse impact on patient care and are linked to unmet mental health needs, turnover, burnout, and relapse. The substance use outreach workforce needs an occupational stress intervention program that addresses both systems and individual occupational challenges while promoting the capacity to engage with the complex demands of delivering safe high-quality substance use care to people who use drugs (PWUD).

Stress First Aid is a promising intervention that has been implemented with several first responder groups and in healthcare settings, but it requires adaptation to the substance use outreach workforce and it needs to be studied against a control group in a rigorous clinical trial. In the R61 planning phase of this study, focus groups comprised of workers and leaders from organizations doing substance use outreach work were convened to adapt the SFA training content and to inform the SFA training delivery methods that were piloted in a field test (N = 35). Findings were integrated into a clinical trial protocol.

In the R33 phase of this study, we will conduct a cluster-randomized hybrid type I trial (N = 500) testing the effectiveness of participation in a 2-hour virtual SFA training and six 30-minute monthly learning collaboratives compared to a no treatment control condition on the following primary outcomes: supervisor and coworker support and burnout. Secondary outcomes are use of SFA concepts, job related affective well-being, secondary traumatic stress, coping strategies, self-efficacy, work engagement, turnover intention, and moral injury symptoms. The long-term goal of our work is to implement a sustainable and effective occupational stress intervention for the substance use outreach workforce nationally in order to strengthen their important role in the substance misuse work force.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • At least 18 years of age
  • In a paid or volunteer role as a substance use outreach worker or community health/outreach worker (whose work includes substance use outreach) with people who use drugs within TX, LA, AR, OK, NM and tribal areas
  • Able and willing to provide informed consent

Exclusion criteria

  • Inability to provide consent

Treatment and study plan

Stress First Aid (SFA)

Behavioral

Stress First Aid for the Substance Use Outreach Workforce is a 2-hour training and up to six virtual 30-minute monthly learning collaborative meetings.

Primary outcomes

  1. Change from Baseline in the Mean Overall Burnout Assessed by the Copenhagen Burnout Inventory at 2 Months

    Time frame: From enrollment to 2 months after the intervention training

    A 19-item, 5-point Likert type scale, where a higher score is a worse outcome. Minimum score of 0, maximum score of 100.

  2. Change from Baseline in the Mean Overall Social Support Assessed by the Job Content Questionnaire Social Support Sub-Scale at 2 Months

    Time frame: From enrollment to 2 months after the intervention training

    An 8-item; 4-point Likert-type scale, where a higher score is a better outcome. Minimum score of 8, maximum score of 40.

Study contacts

Contact information is provided by the study sponsor or research team.

Outreach Coordinator

CONTACT

[email protected]

Project Coordinator

CONTACT

[email protected]

512-495-5277

Sponsors and collaborators

Lead sponsor

University of Texas at Austin

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)

Registry information

Acronym: SFA-Impact

Important dates

Study start
2025
Primary completion
2029
Study completion
2029
First posted
Sep 16, 2025
Registry last updated
Mar 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.